Gene · 667
Papers2,071
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 2,071
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regulation of immune responses by the airway epithelial cell landscape. | Nat Rev Immunol | 2021 | 33442032 | PubTator, text mining | PubMed |
| Gene variations in autism spectrum disorder are associated with alteration of gut microbiota, metabolites and cytokines. | Gut Microbes | 2021 | 33412999 | PubTator, text mining | PubMed |
| Hypoxia and the phenomenon of immune exclusion. | J Transl Med | 2021 | 33407613 | PubTator, text mining | PubMed |
| Predicting changes in renal metabolism after compound exposure with a genome-scale metabolic model. | Toxicol Appl Pharmacol | 2021 | 33387578 | PubTator, text mining | PubMed |
| DReLAB - Deep REinforcement Learning Adversarial Botnet: A benchmark dataset for adversarial attacks against botnet Intrusion Detection Systems. | Data Brief | 2021 | 33365367 | PubTator, text mining | PubMed |
| Prognostic value of BRAF/MIR-17 signature and B-Raf protein expression in patients with colorectal cancer: A pilot study. | J Clin Lab Anal | 2021 | 33296098 | PubTator, text mining | PubMed |
| Global proteomics of Ubqln2-based murine models of ALS. | J Biol Chem | 2021 | 33277362 | PubTator, text mining | PubMed |
| The phenotypic and transcriptomic effects of developmental exposure to nanomolar levels of estrone and bisphenol A in zebrafish. | Sci Total Environ | 2021 | 33243503 | PubTator, text mining | PubMed |
| Proteomic analysis of human iPSC-derived sensory neurons implicates cell stress and microtubule dynamics dysfunction in bortezomib-induced peripheral neurotoxicity. | Exp Neurol | 2021 | 33129842 | PubTator, text mining | PubMed |
| N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease. | Proteomics | 2021 | 33111431 | PubTator, text mining | PubMed |
| Epigenome-wide analysis reveals functional modulators of drug sensitivity and post-treatment survival in chronic lymphocytic leukaemia. | Br J Cancer | 2021 | 33082556 | PubTator, text mining | PubMed |
| More Severe Erosive Phenotype Despite Lower Circulating Autoantibody Levels in Dipeptidyl Peptidase-4 Inhibitor (DPP4i)-Associated Bullous Pemphigoid: A Retrospective Cohort Study. | Am J Clin Dermatol | 2021 | 33026629 | PubTator, text mining | PubMed |
| Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. | J Cell Physiol | 2021 | 32959892 | PubTator, text mining | PubMed |
| Danish premature birth rates during the COVID-19 lockdown. | Arch Dis Child Fetal Neonatal Ed | 2021 | 32788391 | PubTator, text mining | PubMed |
| MicroRNA and protein-coding gene expression analysis in idiopathic pulmonary fibrosis yields novel biomarker signatures associated to survival. | Transl Res | 2021 | 32711186 | PubTator, text mining | PubMed |
| A case of anti-BP230 antibody-positive bullous pemphigoid receiving DPP-4 inhibitor. | Immunol Med | 2021 | 32634333 | PubTator, text mining | PubMed |
| The leucine-rich repeat signaling scaffolds Shoc2 and Erbin: cellular mechanism and role in disease. | FEBS J | 2021 | 32558243 | PubTator, text mining | PubMed |
| Nephron number and its determinants: a 2020 update. | Pediatr Nephrol | 2021 | 32350665 | PubTator, text mining | PubMed |
| HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons. | Front Pharmacol | 2020 | 33584306 | PubTator, text mining | PubMed |
Gene Expression Profiling Reveals the Shared and Distinct Transcriptional Signatures in Human Lung Epithelial Cells Infected With SARS-CoV-2, MERS-CoV, or SARS-CoV: Potential Implications in Cardiovascular Complications of COVID-19. | Front Cardiovasc Med | 2020 | 33521069 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/667/papers?page=31